Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Male pattern baldness does not cause an increased risk of prostate cancer.

Certain genetic variants increase the risk of aggressive prostate cancer.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Diabetes may lower the risk of prostate cancer.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.